NeuroOne Medical Technologies Corporation (NMTC)

NMTC Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	3.56	6.57	1.46	5.32	8.16	6.9
Short-Term Investments	-	-	-	-	2.98	-
Cash & Short-Term Investments	3.56	6.57	1.46	5.32	11.14	6.9
Cash Growth	213.98%	350.01%	-72.57%	-52.23%	61.44%	70.98%
Accounts Receivable	2.66	1.26	0.18	-	0.03	0.05
Inventory	1.67	2.23	2.64	1.73	0.7	0.1
Other Current Assets	0.18	0.16	0.36	0.26	0.3	0.24
Total Current Assets	8.07	10.23	4.63	7.31	12.18	7.29
Net Property, Plant & Equipment	0.47	0.51	0.67	0.69	0.53	0.51
Other Intangible Assets	0.04	0.04	0.07	0.09	0.11	0.13
Total Assets	8.58	10.79	5.37	8.1	12.82	7.94
Accounts Payable	0.55	1.01	1.03	0.69	0.93	0.53
Accrued Expenses	0.71	1.29	1.18	1.11	0.72	0.64
Unearned Revenue	-	-	-	-	1.46	0.01
Total Current Liabilities	1.26	2.3	2.21	1.79	3.1	1.18
Long-Term Leases	0.11	0.14	0.19	0.06	0.12	0.2
Other Long-Term Liabilities	0.81	1.27	2.14	-	-	-
Total Long-Term Liabilities	0.92	1.41	2.33	0.06	0.12	0.2
Total Liabilities	2.18	3.71	4.55	1.85	3.22	1.38
Common Stock	0.05	0.05	0.03	0.02	0.02	0.01
Additional Paid-in Capital	86.4	85.63	75.8	68.91	60.41	47.37
Retained Earnings	-80.05	-78.61	-75	-62.69	-50.83	-40.83
Shareholders' Equity	6.4	7.07	0.82	6.25	9.6	6.55
Total Liabilities & Equity	8.58	10.79	5.37	8.1	12.82	7.94
Total Debt	0.11	0.14	0.19	0.06	0.12	0.2
Net Cash (Debt)	3.45	6.43	1.27	5.27	11.02	6.7
Net Cash Growth	-46.30%	407.82%	-75.97%	-52.21%	64.54%	141.40%
Net Cash Per Share	-	-	0.05	0.29	0.69	0.63
Book Value	6.4	7.07	0.82	6.25	9.6	6.55
Book Value Per Share	-	-	0.03	0.34	0.60	0.61
Tangible Book Value	6.36	7.03	0.75	6.16	9.49	6.42
Tangible Book Value Per Share	-	-	0.03	0.34	0.59	0.60

Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q